Article History
Received: 8 February 2016
Accepted: 11 July 2016
First Online: 2 September 2016
Competing interests
: RJ Haynes: Alcon ocriplasmin advisory board member. D Steel: Alcon Consultancy, Research funding. DAH Laidlaw: Alcon ocriplasmin advisory board member. This work received no support in the form of grants, equipment or drugs.
: The authors declare no conflict of interest.